Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werder

Showing results (371-380 of 376) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 376 results.
American Journal of Respiratory and Critical Care Medicine|December 3, 2021
Targeting the P2Y<sub>13</sub> Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental AsthmaRhiannon B Werder, Md Ashik Ullah, Muhammed Mahfuzur Rahman, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.
Iscience|May 21, 2026
Application of spatial transcriptomics across organoids for a high-resolution, spatial whole-transcriptome benchmarking datasetMaria Rosaria Nucera, Natalie Charitakis, Ryan F Leung, et al.
Molecular Cell|December 1, 2020
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2Ryan M Hekman, Adam J Hume, Raghuveera Kumar Goel, et al.
Pageof 38

Showing results (371-380 of 376) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 376 results.
American Journal of Respiratory and Critical Care Medicine|December 3, 2021
Targeting the P2Y<sub>13</sub> Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental AsthmaRhiannon B Werder, Md Ashik Ullah, Muhammed Mahfuzur Rahman, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.
Iscience|May 21, 2026
Application of spatial transcriptomics across organoids for a high-resolution, spatial whole-transcriptome benchmarking datasetMaria Rosaria Nucera, Natalie Charitakis, Ryan F Leung, et al.
Molecular Cell|December 1, 2020
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2Ryan M Hekman, Adam J Hume, Raghuveera Kumar Goel, et al.
Pageof 38